Inicio › Cáncer de pulmón de células no pequeñas › Florida

Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Florida

164 estudios sobre Cáncer de pulmón de células no pequeñas buscan participantes en Florida.

Ciudades en Florida

Texto oficial del estudio (inglés)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Boca Raton Clinical Research Coral Springs, Coral Springs
Regis Clinical Research LLC, Miami
Florida Clinical Trials Group Tamarac, Tamarac

ReclutandoFase 3

Edades de 18 a 100 · Todos los sexos · Actualizado el 13 nov 2026 · NCT05920356

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Miami Cancer Institute, Miami

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07488676

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

BRCR Global - Coral Springs, Coral Springs
BRCR Global- Tamarac, Tamarac
Moffit Cancer Centre, Tampa

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07659782

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Moffit Cancer Center, Tampa

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07111520

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Local Institution - 0142, Pembroke Pines

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07100080

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

The Oncology Institute of Hope and Innovation ( Site 0161), Fort Lauderdale

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07190248

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Mid Florida Hematology and Oncology Center, Orange City
BRCR Global, Plantation

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Morton Plant Hospital, Clearwater
Miami Cancer Institute, Miami
South Florida Baptist Hospital, Plant City
y 6 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
Holy Cross Hospital, Fort Lauderdale
Regional Cancer Center-Lee Memorial Health System, Fort Myers
y 6 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Cancer Specialists of North Florida - Fleming Island, Fleming Island
Cancer Specialists of North Florida - Riverside, Jacksonville
Cancer Specialists of North Florida Southside, Jacksonville
y 6 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06472245

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Holy Cross Hospital-Fort Lauderdale-57892, Fort Lauderdale

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04886804

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona, Orlando

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06914128

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Mayo Clinic in Florida ( Site 0014), Jacksonville
Mount Sinai Cancer Center ( Site 0038), Miami Beach
Mid Florida Hematology and Oncology Center ( Site 0018), Orange City

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06312137

A Study of DS-3939a in Participants With Solid Tumors

Moffitt Cancer Center - Magnolia Campus, Tampa

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07739966

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

Cleveland Clinic Weston Hospital, Weston

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06868485

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

AdventHealth Celebration, Celebration
Florida Clinical Trials Group, Plantation
Florida Cancer Specialists, Sarasota

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07503808

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

Local Institution - 0527, Fort Myers
Local Institution - 0366, Orlando
Cancer Care Centers of Brevard - Rockledge, Palm Bay
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07680790

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Fort Myers
Research Site, Jacksonville
Research Site, St. Petersburg
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07291037

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Baptist MD Anderson Cancer Center, Baptist Health, Jacksonville
Florida Cancer Affiliates - Ocala Oncology, Ocala
Moffitt Cancer Center, Tampa

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06216301

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

The Oncology Institute of Hope and Innovation - Fort Lauderdale ( Site 0156), Fort Lauderdale
Miami Cancer Institute at Baptist Health, Inc. ( Site 0214), Miami

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06623422

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

UF Health Cancer Center ( Site 3257), Gainesville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07513376

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

Bay Pines VA Healthcare System, Bay Pines

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07541170

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Florida Cancer Specialists - North, St. Petersburg
Florida Clinical Trials Group., Tamarac
Florida Cancer Specialists - East, West Palm Beach

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06561386

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

Baptist Health - Boca Raton Regional Hospital, Boca Raton

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07566052

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Florida Cancer Specalists, Sarasota
Moffitt Cancer Center, Tampa

ReclutandoFase 1

Edades de 18 a 99 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06983743

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Clermont Oncology Center, Clermont
Mid Florida Hematology and Oncology Center, Orange City

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Cancer Care Centers of Brevard, Inc., Palm Bay
Florida Cancer Affiliates - Panama City, Panama City

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07144280

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Florida Cancer Specialists - SOUTH - SCRI - PPDS, Fort Myers
University of Florida Health at Shands, Gainesville
BioResearch Partner, Hialeah
y 6 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Florida Cancer Specialists - SOUTH - SCRI - PPDS, Fort Myers
Florida Cancer Specialists - NORTH - SCRI - PPDS, St. Petersburg
Florida Cancer Specialists - EAST - SCRI - PPDS, West Palm Beach

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT05789082

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Local Institution - 0711, Ocala
Florida Clinical Trials Group, Tamarac

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07361497

Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC

Helios CR, Inc. - The Oncology Institute of Hope and Innovation - Fort Lauderdale, Fort Lauderdale
Florida Clinical Trials Group, LLC, Plantation
Florida Clinical Trials Group, Plantation

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07777822

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Boca Raton Regional Hospital, Boca Raton
Florida Cancer Specialists - South, Fort Myers
Miami Cancer Institute at Baptist Health, Inc., Miami
y 5 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06890598

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Florida Cancer Specialists - Lake Nona, Orlando
Florida Cancer Specialists - Sarasota, Sarasota

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06150664

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Mayo Clinic - Florida, Jacksonville
Sarah Cancer Research Institution - Florida Cancer Specialist, Orlando
Moffitt Cancer Center, Tampa

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06706076

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Florida Cancer Specialists South, Fort Myers
USOR Florida Cancer Specialists North, St. Petersburg
USOR Florida Cancer Specialists East, West Palm Beach

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Morton Plant Hospital, Clearwater
South Florida Baptist Hospital, Plant City
Saint Anthony's Hospital Cancer Care Center, St. Petersburg
y 2 más

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06418204

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Holy Cross Hospital (site 213), Fort Lauderdale
Memorial Cancer Institute at Memorial Healthcare Systems (site 132), Pembroke Pines

ReclutandoFase 1/2

Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT03556228

SI-B036-ST-101 in Advanced/Metastatic Solid Tumors

Florida Cancer Specialists Lake Nona, Orlando
Florida Cancer Specialists Sarasota, Sarasota

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07857616

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Millennium Oncology Research Clinic, Hollywood
Miami Cancer Institute at Baptist Health, Inc., Miami
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Memorial Regional Hospital, Hollywood
Memorial Cancer Institute, Pembroke Pines

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06667076

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.